胎儿代谢应激破坏HIV-1及联合抗逆转录病毒治疗暴露婴儿的免疫稳态并诱导促炎反应
研究探讨母体HIV-1感染及联合抗逆转录病毒治疗(cART)暴露对婴儿免疫代谢组的影响。代谢组学分析显示,cART/HIV-1暴露婴儿存在过氧化脂质增加、甘油三酯升高、磷脂减少,促炎介质(溶血磷脂、CXCL10、CCL3)升高而抗炎代谢物降低,提示胎儿代谢受母体因素影响并使新生儿免疫反应偏向炎症。
要点
- cART/HIV-1暴露婴儿过氧化脂质增加,提示线粒体功能改变。
- 暴露婴儿脂代谢紊乱:甘油三酯升高、磷脂降低。
- 暴露婴儿促炎介质升高、抗炎代谢物降低,免疫反应偏向炎症。
核心结论
- 母体cART和HIV-1影响胎儿代谢,使新生儿生理性免疫反应偏向炎症。
研究设计与样本
- 采用新型代谢组学技术研究胎儿HIV-1和cART暴露对婴儿免疫代谢组的影响。
主要发现
- cART/HIV-1暴露婴儿中活性氧产生的过氧化脂质增加,提示线粒体功能改变。
- 与对照婴儿相比,cART/HIV-1暴露婴儿甘油三酯种类增加、磷脂减少,脂代谢进一步失调。
- cART/HIV-1暴露婴儿促炎免疫介质溶血磷脂及CXCL10、CCL3等细胞因子增加,而细胞色素P450通路的抗炎代谢物减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Increased morbidity and fetal growth restriction are reported in uninfected children born to human immunodeficiency virus type 1 (HIV-1)-infected women treated with antiretroviral (ARV) therapy. Viruses and/or pharmacological interventions such as ARVs can induce metabolic stress, skewing the cell's immune response and restricting (cell) growth. Novel metabolomic techniques provided the opportunity to investigate the impact of fetal HIV-1 and combination ARV therapy (cART) exposure on the infants' immune metabolome. Peroxidized lipids, generated by reactive oxygen species, were increased in cART/HIV-1-exposed infants, indicating altered mitochondrial functioning. The lipid metabolism was further dysregulated with increased triglyceride species and a subsequent decrease in phospholipids in cART/HIV-1-exposed infants compared to control infants. Proinflammatory immune mediators, lysophospholipids as well as cytokines such as CXCL10 and CCL3, were increased whereas anti-inflammatory metabolites from the cytochrome P450 pathway were reduced in cART/HIV-1-exposed infants. Taken together, these data demonstrate that the fetal metabolism is impacted by maternal factors (cART and HIV-1) and skews physiological immune responses toward inflammation in the newborn infant.
引用
- Schoeman JC, Moutloatse GP, Harms AC, et al. Fetal Metabolic Stress Disrupts Immune Homeostasis and Induces Proinflammatory Responses in Human Immunodeficiency Virus Type 1- and Combination Antiretroviral Therapy-Exposed Infants. J Infect Dis. 2017. PMID: 28633455. doi:10.1093/infdis/jix291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。